Programme - Global Summit for Precision Psychiatry
![Logo Global Summit for Precision Psychiatry Logo Global Summit for Precision Psychiatry](/system/files/styles/1_1_high/private/images/SITE%20INTERNET_0.jpg.webp?itok=R40rgEbp)
MAY 15th | SETTING THE STAGE
6:30 pm - 7:30 pm
- Goals, Successes & Challenges in Precision Psychiatry, Marion Leboyer, FR
- Wrap-up of the ECNP New Frontiers meeting on Precision Psychiatry, Martien Kas, NL
- Lessons from the past, Andy Miller, USA
MAY 16th | FROM INSPIRATION TO IMPLEMENTATION
9:00 am - 9:15 am
Chair, Marion Leboyer, UPEC, Fondation FondaMental & PEPR PROPSY, FR & Brenda Pennix, Amsterdam UMC, NL.
9:15 am - 10:00 am
Lessons learned in precision medicine from neurology and oncology
- Brain imaging and biomarkers as crucial tools for a future with precision medicine in Alzheimer’s disease, Wiesje van der Flier, NL
- The example of precision immuno-microbio-oncology, Laurence Zitvogel, FR
10:30 am - 12:30 pm
Precision psychiatry: Successes
- Inflammation, Carmine Pariante, UK
- Immuno-metabolism, Brenda Penninx, NL
- Imaging in brain stimulation, Charles Laidi, FR
- A mechanism-based strategy in Autism, Lynn Durham, CH
Q&A 30 min and Wrap-up
2:00 pm - 2:10 pm
Chairs, Carinne Brouillon, Boehringer Ingelheim, DE, Andy Miller, Emory University, USA
2:10 pm - 3:30 pm
Enrichment and stratification tools in Precision Psychiatry
- Biomarker consortium: tool towards stratification in Psychiatry, Alessio Travaglia, US
- Proteomics: tools for Precision Psychiatry, Anne-Li Lind, SE
- Anhedonia as an outcome measure, Wayne Drevets, USA
4:00 pm - 5:30 pm
Tools Towards Precision Psychiatry
- Establishing targets and risk, Elisabeth Binder, DE
- AI for Health: Challenges & Solutions, Emmanuel Bacry, FR
- Using machine learning to extract new transdiagnostic categories, Paris Lalousis, UK
- Digital tools, Inez Myin-Germys, BE
5:30 pm - 6:30 pm
Concluding remarks, Andrzej Rys, Principal Scientific Adviser DG SANTE, European Commission, BE
MAY 17th | THE WAY FORWARD
10:00 am - 10:15 am
Chairs, Vikas Mohan Sharma, Fortrea, DE, Pawel Swieboda, BE, NeuroCentury, BE
10:15 am - 11:30 am
Strategies for Drug development
- The levers needed to accelerate innovative drug discovery and progress through development, Hugh Marston, DE
- Strategies to design more precise clinical development programmes (hopefully) shorten time to market? Vikas Mohan Sharma, DE
- Real world data towards drug development in Psychiatry, Nawal Roy, USA
- Multimodal biomarkers strategies in psychiatry, Andreas Meyer-Lindenberg, DE
11:50 am - 12:10 pm
Dimensional approach for psychiatric disorders, implications in clinical trials and regulatory setting, Florence Butlen-Ducuing, European Medicines Agency
12:10 pm - 1:10 pm
Vision from stakeholders
- Patients’ perspectives on Precision Psychiatry, Peter Keri, GAMIAN, HU
- The research domain criteria (RDoC) project as framework for Precision Psychiatry, Bruce Cuthbert, NIMH, USA
- Future of the DSM towards Precision Psychiatry, Nitin Gogtay, APA, USA
1:10 pm - 1:30 pm
Chairs, Marion Leboyer, Brenda Pennix, Martien Kas, Andy Miller : Call to actions
MAY 17th | WORK GROUPS
2:30 pm - 6:30 pm
- Scientific papers PI: Andy Miller, USA
- Policy Brief PI: Véronique Briquet-Laugier,FR
► Download the program of the International Summit on Precision Medicine in Psychiatry